{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T05:34:17Z","timestamp":1772084057316,"version":"3.50.1"},"reference-count":14,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Homeopathy"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\n          Background\u2003COVID-19 quickly became a serious public health problem worldwide, with serious economic and social repercussions. Homeopaths around the world have been studying to find a genus epidemicus (GE) medicine that might help in the prevention and treatment of this disease.<\/jats:p><jats:p>\n          Objective\u2003To compare the incidence of COVID-19 between employees who received or did not receive a homeopathic GE medicine for disease prevention.<\/jats:p><jats:p>\n          Methods\u2003Retrospective cohort analysis. The study population comprised all employees of a service sector company in S\u00e3o Paulo, Brazil, and followed up by the corporate Occupational Health department. Intervention consisted of administering Arsenicum album 30cH in a one-weekly dose. Primary outcome was incidence of COVID-19 during 3-months' follow-up (April to July, 2020).<\/jats:p><jats:p>\n          Results\u2003We analyzed 1,642 of 1,703 employees without previous diagnosis of COVID-19 at onset of the study period: 53.34% of employees were referred to telework at home and did not receive intervention (Group 1, G1); 24.66% remained working on-premises in the state of S\u00e3o Paulo and received the intervention (Group 2, G2); 21.98% remained working on company premises in other states and did not receive intervention (Group 3, G3). Incidence rate of COVID-19 was respectively 13.35%, 0.74%, and 67.87% (p\u2009&lt;\u20090.001). The odds ratio of being infected in (1) G3 versus G1 was 13.70 (95% confidence interval [CI], 10.21 to 18.39), (2) G3 versus G2 was 283.02 (95% CI, 88.98 to 900.18), and (3) G1 versus G2 was 20.66 (95% CI, 6.53 to 65.39).<\/jats:p><jats:p>\n          Limitations\u2003The present is a retrospective analysis of a real-world experience. We could not ensure direct observed treatment, and neither could we control adherence to general prevention measures outside company premises.<\/jats:p><jats:p>\n          Conclusion\u2003The incidence of COVID-19 was significantly lower amongst on-premises employees who received the GE medication in comparison to workers who did not receive the intervention (those either at other company premises or teleworking at home).<\/jats:p>","DOI":"10.1055\/s-0041-1733972","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:19:22Z","timestamp":1634689162000},"page":"105-112","source":"Crossref","is-referenced-by-count":13,"title":["Homeopathy for COVID-19 Prevention: Report of an Intervention at a Brazilian Service Sector Company"],"prefix":"10.1055","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6630-2277","authenticated-orcid":false,"given":"Paulo Sergio Jord\u00e3o","family":"Daruiche","sequence":"additional","affiliation":[{"name":"Escola de Homeopatia de S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter Swain","family":"Canoas","sequence":"additional","affiliation":[{"name":"Escola de Homeopatia de S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katya Aparecida Gon\u00e7alves","family":"Figueira","sequence":"additional","affiliation":[{"name":"Escola de Homeopatia de S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovani Bravin","family":"Peres","sequence":"additional","affiliation":[{"name":"Research Center, Graduation Program in Environmental and Experimental Pathology, Universidade Paulista-UNIP, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2021,10,19]]},"reference":[{"key":"ref3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1055\/s-0040-1714053","article-title":"The Hydra-headed coronaviruses: implications of COVID-19 for homeopathy","volume":"109","author":"S Waisse","year":"2020","journal-title":"Homeopathy"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.homp.2012.01.001","article-title":"The science of high dilutions in historical context","volume":"101","author":"S Waisse","year":"2012","journal-title":"Homeopathy"},{"key":"ref7","volume-title":"Escritos menores","author":"S Hahnemann","year":"2006"},{"key":"ref8","first-page":"1","article-title":"Homeopathy and dengue: Maca\u00e9, Rio de Janeiro, Brazil, 2007\u20132012","volume":"79","author":"L AS Nunes","year":"2016","journal-title":"Rev Homeopatia (S\u00e3o Paulo)"},{"key":"ref9","first-page":"1","article-title":"Report on the use of homeopathic medication in the prophylaxis of dengue in Belo Horizonte, Minas Gerais, Brazil, in 2010","volume":"75","author":"C Prass-Santos","year":"2012","journal-title":"Rev. homeopatia (S\u00e3o Paulo)"},{"key":"ref10","volume-title":"Homeopatia nas epidemias: estudo de caso com base em experi\u00eancias recentes","author":"P SJ Daruiche","year":"2012"},{"key":"ref11","volume-title":"Organon da arte de curar. 6th ed","author":"S Hahnemann","year":"2007"},{"key":"ref18","volume-title":"Repertory of the homoeopathic materia medica","author":"J T Kent","year":"2001"},{"key":"ref19","volume-title":"Doen\u00e7as cr\u00f4nicas","author":"S Hahnemann","year":"1998"},{"key":"ref20","volume-title":"Mat\u00e9ria m\u00e9dica pura","author":"S Hahnemann","year":"1998"},{"key":"ref27","volume-title":"Statistical power analysis for the behavioral sciences (2nd ed.)","author":"J Cohen","year":"1988"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e00149420","DOI":"10.1590\/0102-311x00149420","article-title":"SRAG por COVID-19 no Brasil: descri\u00e7\u00e3o e compara\u00e7\u00e3o de caracter\u00edsticas demogr\u00e1ficas e comorbidades com SRAG por influenza e com a popula\u00e7\u00e3o geral","volume":"36","author":"R P Niquini","year":"2020","journal-title":"Cad Saude Publica"},{"key":"ref30","first-page":"160","article-title":"Homeopathic remedies in COVID-19: prognostic factor research","volume":"110","author":"R K Manchanda","year":"2021","journal-title":"Homeopathy"},{"key":"ref31","first-page":"198","article-title":"Clinical repurposing of medicines is intrinsic to homeopathy: research initiatives on COVID-19 in India","volume":"110","author":"R Varanasi","year":"2021","journal-title":"Homeopathy"}],"container-title":["Homeopathy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1733972.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T22:58:57Z","timestamp":1653001137000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0041-1733972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,19]]},"references-count":14,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2022,5,19]]},"published-print":{"date-parts":[[2022,5]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1733972","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1475-4916","1476-4245"],"issn-type":[{"value":"1475-4916","type":"print"},{"value":"1476-4245","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,19]]}}}